Effects of Ezetimibe Added to Ongoing Statin Therapy on C-Reactive Protein Levels in Hypercholesterolemic Patients

BACKGROUND AND OBJECTIVES: Ezetimibe alone does not decrease C-reactive protein (CRP) levels in hypercholesterolemic patients. However, several reports have suggested that ezetimibe might potentiate the effect of statin not only on cholesterol but also on CRP when administered together. We investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Min Seok, Min, Yun Joo, Kwon, Jee Eun, Cho, Eun Jeong, Kim, Jung Eun, Lee, Wang-Soo, Lee, Kwang Je, Kim, Sang-Wook, Kim, Tae Ho, Kim, Chee Jeong, Ryu, Wang Seong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116103/
https://www.ncbi.nlm.nih.gov/pubmed/21731566
http://dx.doi.org/10.4070/kcj.2011.41.5.253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116103/
https://www.ncbi.nlm.nih.gov/pubmed/21731566
http://dx.doi.org/10.4070/kcj.2011.41.5.253

Ejemplares similares